- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03670225
Evaluating Clinical Acceptance of a NPWT Wound Care System
Evaluating Clinical Acceptance of a NPWT Wound Care System to Expected Standards of Care in Post-acute Patients With a Variety of Wound Types
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The primary objective of this study is to determine acceptable progress towards the goal of therapy for a diabetic foot ulcers (DFU) and pressure Injuries/ulcers (PI/PU) wounds when using the Medela Invia Motion Endure NPWT system during 4-week study duration.
Goal of therapy will be defined by the physician according to initial assessment:
Endpoints (dependent on goal of therapy):
- Decrease in wound volume
- Decrease in size of the tunneling area
- Decrease in size of undermining
- Decrease in amount of slough
- Increase in granulation tissue
- The wound bed is progressing acceptably towards a transition to another treatment modality such as Moist Wound Healing (MWH), surgical closure, or a flap or graft.
**Study endpoint will be determined by physician at the time of enrollment, when the goal of therapy is documented**
B. Secondary Objectives
- To evaluate the ease of use from clinicians.
- To evaluate overall satisfaction from clinicians. C. Tertiary Objectives
- Adequate management of the exudate
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Georgia
-
Augusta, Georgia, Forenede Stater, 30909
- Joseph M. Still Research Foundation
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Adult subjects ≥18 years of age.
- Signed, informed consent by patient or LAR within 72 hours of admission to burn center.
- Patient is determined to be in need of NPWT for treatment of a diabetic foot ulcer, pressure injuries/pressure ulcer.
- Patient is comfortable (e.g. not in pain)
- Patient is willing and able to adhere to treatment protocol.
Exclusion Criteria:
- Patient not willing to comply with f/u clinic visits.
Subjects with
- Necrotic tissue with eschar present
- Untreated osteomyelitis
- Non-enteric and unexplored fistulas
- Malignancy in wound
- Exposed vasculature
- Exposed nerves
- Exposed anastomotic site of blood vessels or bypasses
- Exposed organs
- Subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures.
- Patients with concurrent conditions or co-morbidities that in the opinion of the investigator may compromise patient safety or study objectives.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Andet: Invia Motion Endure
|
NPWT Invia Motion Endure
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Determine if Invia Motion Endure supports acceptable progress towards the goal of therapy for DFU and PI/PU wounds
Tidsramme: 4 weeks
|
Goal of the therapy will be defined by the physician according to initial assessment:
**Study endpoint will be determined by physician at the time of enrolment, when the goal of therapy is documented** |
4 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Evaluation of ease of use and satisfaction
Tidsramme: 4 weeks
|
A weekly survey will be obtained from the wound clinic staff members to determine ease of use and satisfaction
|
4 weeks
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Adequate management of the exudate
Tidsramme: 4 weeks
|
Measurament of exudate (ml, number of canisters used) will be performed
|
4 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Robert F Mullins, MD, Joseph M. Still Research Foundation
Publikationer og nyttige links
Generelle publikationer
- Sen CK, Gordillo GM, Roy S, Kirsner R, Lambert L, Hunt TK, Gottrup F, Gurtner GC, Longaker MT. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen. 2009 Nov-Dec;17(6):763-71. doi: 10.1111/j.1524-475X.2009.00543.x.
- Morrison Informatics, Inc. A comprehensive cost analysis of medicare home oxygen therapy: A study for the American Association for Homecare. June 27, 2006.
- C. Marquardt et. al. "Negative pressure wound therapy using PHMB gauze for the management of postoperative subcutaneous surgical site infections" Coloproctology" 36:364-369, 2014
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- HC1801
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Diabetisk fodsår
-
Assiut UniversityUkendtom Vitreomacular Interface Abnormalities in Diabetic Retinopathy
Kliniske forsøg med Invia Motion Endure
-
Indiana UniversityMedela AGAfsluttet
-
Medela AGJoseph M. Still Research Foundation, Inc.AfsluttetØdem | Kirurgisk sår | Diabetisk fodsår | Tryksår | Trykskade | Akut sår | Traumatisk sår | DehiscensForenede Stater
-
U.S. Wound RegistryUkendtForbrændinger | Diabetiske fodsår | Tryksår | Kirurgisk sår dehiscens | Venøs stasis sår | Andre typer af kroniske ikke-helende sårForenede Stater
-
University of Missouri-ColumbiaAfsluttet
-
Grupo de Investigación en Actividad Física y SaludAfsluttetKræftoverlevereSpanien
-
Afyonkarahisar Health Sciences UniversityAfsluttetMuskuloskeletale sygdomme | Albue tendinitis | Lateral epikondylitis | Blodpladerigt plasma (PRP)Kalkun
-
University of MinnesotaRekrutteringBarnekræft | Hæmatoietisk celletransplantationForenede Stater
-
Loma Linda UniversityAfsluttet
-
Texas Tech University Health Sciences Center, El...AfsluttetOvergangsalderen
-
Northwestern Health Sciences UniversityHealth Resources and Services Administration (HRSA); University of Western...Afsluttet